@Renal_Ints profile picture
Renal Interventions @Renal_Ints

#Renal Interventions is a specialised digital publication providing news and insight to a multidisciplinary audience in the #kidney care field.

Joined February 2021
  • Tweets 1,053
  • Following 562
  • Followers 934
369 Photos and videos
Amplifi Vascular recently announced the successful initiation of the AMPLIFI-1 trial at Brigham and Women’s Hospital in Boston, USA renalinterventions.net/ampli…

AMPLIFI-1 pivotal trial launched to assess vein dilation system for distal AVF creation - Renal...

Amplifi Vascular recently announced the successful initiation of the AMPLIFI-1 trial at Brigham and Women's Hospital in Boston, USA.

renalinterventions.net
3
141
Listening to “vibrational” changes in blood flow could offer promise for AVF surveillance renalinterventions.net/liste…

Listening to “vibrational” changes in blood flow could offer promise for AVF surveillance - Renal...

Researchers have tested a new method of assessing arteriovenous fistula (AVF) dysfunction, using a small acoustic sensor to detect vibrational differences in blood flow between dysfunctional and...

renalinterventions.net
73
Renal Interventions retweeted
Vascular News@VascularNews
Jan 27
Revolutionising care: Drug-eluting stent platform designed to address edge restenosis (Leonardo Harduin and Peter Schneider). Watch the full interview here: vascularnews.com/revolutioni… #DialysisAccess #Endovascular This post is sponsored by Solaris Endovascular

Revolutionising care: Drug-eluting stent platform designed to address edge restenosis poised to...

Effective, durable options to address faltering dialysis access circuits have remained elusive, leaving a significant unmet need in long-term access maintenance. Until now. Promising interim data...

vascularnews.com
1
1
323
US FDA clears Archimedes home dialysis system from @simergent renalinterventions.net/us-fd…

US FDA clears Archimedes home dialysis system - Renal Interventions

Simergent has announced 510(k) clearance from the US Food and Drug Administration (FDA) for the Archimedes automated peritoneal dialysis (APD) system for the treatment of patients with end-stage...

renalinterventions.net
1
82
Renal Interventions retweeted
VASBI VascularAccess@VASBImedia
25 Sep 2025
VASBI President Jeremy Crane introduces this year’s AGM. Phenomenal line up of speakers and presentations with a national and international faculty. #VASBI2025
3
8
508
Frank Dor and Andrew Garnham debate whether current vascular access training is adequate #CX2025
1
2
3
311
The #CX2025 audience agrees with Garnham’s assertion that vascular access training IS inadequate
1
129
Nicholas Inston opens the Vascular Access Masterclass at #CX2025, setting the scene for the day’s session which will probe vascular access challenges, and the need to find the right access, for the right patient at the right time
1
1
1
276
Karen Stevenson sets out information needs for clinicians and patients in vascular access #CX2025
1
1
141
.@robshahverdyan offers an update on endoAVF trials, acknowledging that challenges now exist with the impending withdrawal of Ellipsys from the market #CX2025
1
3
280
Renal Interventions retweeted
Vascular News@VascularNews
13 Mar 2025
"I'm very intrigued by what's going on in xenotransplantation" Bart Dolmatch looks ahead to the future of care for #haemodialysis patients during yesterday's @VascularNews LIVE broadcast. Watch the discussion here: vascularnews.com/vascularnew…
1:13
2
2
808
Renal Interventions retweeted
Vascular News@VascularNews
13 Mar 2025
“I think we keep our eyes on the evolution of the treatment algorithm” Kate Steiner outlines future priorities in #VascularAccess care during yesterday's @VascularNews LIVE broadcast, which can be viewed on demand here: vascularnews.com/vascular-ne…
0:33
2
2
881
Renal Interventions retweeted
Vascular News@VascularNews
13 Mar 2025
Are we on the cusp of pharmacological management for AV fistulas? @nick_inston shares what #VascularAccess data he looks forward to in the near future as part of yesterday's @VascularNews LIVE broadcast. Watch the discussion here: vascularnews.com/vascularnew…
0:43
2
2
810
Renal Interventions retweeted
Vascular News@VascularNews
9 Mar 2025
Great to speak with Maarten Snoeijs at #EVC2025 to discuss this year’s vascular access programme at the meeting as well as the ongoing OASIS trial. Stay tuned for the video interview #VascularAccess #Haemodialysis
1
3
666
.@medibeacon has won FDA approval for the MediBeacon TGFR system for the assessment of kidney function in patients with normal or impaired renal function. TGFR uses an intravenous Lumitrace injection but does not require blood draws or urine analysis renalinterventions.net/medib…

US FDA approval for transdermal GFR assessment system - Renal Interventions

MediBeacon has announced US Food and Drug Administration (FDA) approval of the MediBeacon TGFR for the assessment of kidney function in patients with normal or impaired renal function.

renalinterventions.net
1
2
182
Centers for Medicare & Medicaid Services is opening a national coverage analysis on renal denervation, with a view to reviewing and developing a national Medicare coverage policy for the therapy for patients with hypertension @Medtronic @ReCorMedical renalinterventions.net/cms-l…

CMS launches review of coverage for renal denervation - Renal Interventions

The Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) of renal denervation, with a view to reviewing and developing a national Medicare coverage policy for...

renalinterventions.net
102
As a part of the 2024 @VEITHsymposium, @DillavouEllen presented new data about the SelfWrap (VenoStent) bioabsorbable perivascular wrap, outlining how the novel device can, in her words, improve arteriovenous fistula (AVF) maturation and patency renalinterventions.net/novel…

Novel bioabsorbable perivascular wrap aims to reduce AVF failure - Renal Interventions

As a part of the Novel technologies in haemodialysis access session on the final day of the 2024 VEITHsymposium (19–23 November, New York, USA), Ellen Dillavou (WakeMed Heart Center, Raleigh, USA),...

renalinterventions.net
1
113
At @VEITHsymposium 2024, Robert E Lee, a medical officer recently retired from the @US_FDA, presented his argument for when the use of RCTs for the regulation and approval of novel vascular access devices becomes important renalinterventions.net/veith…

VEITH audience hears when RCTs are essential for novel vascular access device regulation and...

As a part of a debate on the last day of the 2024 VEITHsymposium (19–23 November, New York, USA), Robert E Lee, a medical officer recently retired from the US Food and Drug Administration (FDA),...

renalinterventions.net
110
.@RevBio1 recently announced that the US FDA has accepted its investigational new drug (IND) application for Gemini renalinterventions.net/revel…

Revelation Biosciences announces US FDA acceptance of Gemini IND - Renal Interventions

Revelation Biosciences recently announced that the US Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for Gemini. The company referred to this accepta...

renalinterventions.net
78
.@RockwellMedical, a healthcare company that develops, manufactures, commercialises, and distributes a portfolio of haemodialysis products to dialysis providers worldwide, today announced that Jesse Neri was promoted to chief financial officer (CFO) renalinterventions.net/rockw…

Rockwell Medical promotes Jesse Neri to chief financial officer - Renal Interventions

Rockwell Medical, a healthcare company that develops, manufactures, commercialises, and distributes a portfolio of haemodialysis products to dialysis providers worldwide, today announced that Jesse...

renalinterventions.net
90
Load more